Anti-Smoking Products Market - Global Outlook and Forecast 2022-2028

January 2022 | 66 pages | ID: AC0534E1AE52EN
Market Monitor Global

Abstracts

The smoking cessation and nicotine de-addiction market is categorized into three major segments including drug therapy, Nicotine Replacement Therapy (NRT), and Electronic cigarettes (E-cigarettes).

This report contains market size and forecasts of Anti-Smoking Products in Global, including the following market information:

Global Anti-Smoking Products Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Anti-Smoking Products market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Nicotine Replacement Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Anti-Smoking Products include Pfizer, Cipla, Novartis International, GSK, Takeda pharmaceutical, McNeil AB, Revolymer plc, Imperial Tobacco and Elder Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-Smoking Products companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Anti-Smoking Products Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Anti-Smoking Products Market Segment Percentages, by Type, 2021 (%)

• Nicotine Replacement Therapy
• Drug therapy
• E-cigarettes

Global Anti-Smoking Products Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Anti-Smoking Products Market Segment Percentages, by Application, 2021 (%)

• Smokers aged 18–24
• Smokers aged 25–44
• Smokers aged 45–64
• Smokers aged 65 years or older

Global Anti-Smoking Products Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Anti-Smoking Products Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Anti-Smoking Products revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Anti-Smoking Products revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Cipla
• Novartis International
• GSK
• Takeda pharmaceutical
• McNeil AB
• Revolymer plc
• Imperial Tobacco
• Elder Pharma
• NJOY
• VMR products
• Lorillard
• VaporCorp

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Anti-Smoking Products Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Anti-Smoking Products Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTI-SMOKING PRODUCTS OVERALL MARKET SIZE

2.1 Global Anti-Smoking Products Market Size: 2021 VS 2028
2.2 Global Anti-Smoking Products Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Anti-Smoking Products Players in Global Market
3.2 Top Global Anti-Smoking Products Companies Ranked by Revenue
3.3 Global Anti-Smoking Products Revenue by Companies
3.4 Top 3 and Top 5 Anti-Smoking Products Companies in Global Market, by Revenue in 2021
3.5 Global Companies Anti-Smoking Products Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-Smoking Products Players in Global Market
  3.6.1 List of Global Tier 1 Anti-Smoking Products Companies
  3.6.2 List of Global Tier 2 and Tier 3 Anti-Smoking Products Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Anti-Smoking Products Market Size Markets, 2021 & 2028
  4.1.2 Nicotine Replacement Therapy
  4.1.3 Drug therapy
  4.1.4 E-cigarettes
4.2 By Type - Global Anti-Smoking Products Revenue & Forecasts
  4.2.1 By Type - Global Anti-Smoking Products Revenue, 2017-2022
  4.2.2 By Type - Global Anti-Smoking Products Revenue, 2023-2028
  4.2.3 By Type - Global Anti-Smoking Products Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Anti-Smoking Products Market Size, 2021 & 2028
  5.1.2 Smokers aged 18–24
  5.1.3 Smokers aged 25–44
  5.1.4 Smokers aged 45–64
  5.1.5 Smokers aged 65 years or older
5.2 By Application - Global Anti-Smoking Products Revenue & Forecasts
  5.2.1 By Application - Global Anti-Smoking Products Revenue, 2017-2022
  5.2.2 By Application - Global Anti-Smoking Products Revenue, 2023-2028
  5.2.3 By Application - Global Anti-Smoking Products Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Anti-Smoking Products Market Size, 2021 & 2028
6.2 By Region - Global Anti-Smoking Products Revenue & Forecasts
  6.2.1 By Region - Global Anti-Smoking Products Revenue, 2017-2022
  6.2.2 By Region - Global Anti-Smoking Products Revenue, 2023-2028
  6.2.3 By Region - Global Anti-Smoking Products Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Anti-Smoking Products Revenue, 2017-2028
  6.3.2 US Anti-Smoking Products Market Size, 2017-2028
  6.3.3 Canada Anti-Smoking Products Market Size, 2017-2028
  6.3.4 Mexico Anti-Smoking Products Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Anti-Smoking Products Revenue, 2017-2028
  6.4.2 Germany Anti-Smoking Products Market Size, 2017-2028
  6.4.3 France Anti-Smoking Products Market Size, 2017-2028
  6.4.4 U.K. Anti-Smoking Products Market Size, 2017-2028
  6.4.5 Italy Anti-Smoking Products Market Size, 2017-2028
  6.4.6 Russia Anti-Smoking Products Market Size, 2017-2028
  6.4.7 Nordic Countries Anti-Smoking Products Market Size, 2017-2028
  6.4.8 Benelux Anti-Smoking Products Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Anti-Smoking Products Revenue, 2017-2028
  6.5.2 China Anti-Smoking Products Market Size, 2017-2028
  6.5.3 Japan Anti-Smoking Products Market Size, 2017-2028
  6.5.4 South Korea Anti-Smoking Products Market Size, 2017-2028
  6.5.5 Southeast Asia Anti-Smoking Products Market Size, 2017-2028
  6.5.6 India Anti-Smoking Products Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Anti-Smoking Products Revenue, 2017-2028
  6.6.2 Brazil Anti-Smoking Products Market Size, 2017-2028
  6.6.3 Argentina Anti-Smoking Products Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Anti-Smoking Products Revenue, 2017-2028
  6.7.2 Turkey Anti-Smoking Products Market Size, 2017-2028
  6.7.3 Israel Anti-Smoking Products Market Size, 2017-2028
  6.7.4 Saudi Arabia Anti-Smoking Products Market Size, 2017-2028
  6.7.5 UAE Anti-Smoking Products Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Anti-Smoking Products Major Product Offerings
  7.1.4 Pfizer Anti-Smoking Products Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Cipla
  7.2.1 Cipla Corporate Summary
  7.2.2 Cipla Business Overview
  7.2.3 Cipla Anti-Smoking Products Major Product Offerings
  7.2.4 Cipla Anti-Smoking Products Revenue in Global Market (2017-2022)
  7.2.5 Cipla Key News
7.3 Novartis International
  7.3.1 Novartis International Corporate Summary
  7.3.2 Novartis International Business Overview
  7.3.3 Novartis International Anti-Smoking Products Major Product Offerings
  7.3.4 Novartis International Anti-Smoking Products Revenue in Global Market (2017-2022)
  7.3.5 Novartis International Key News
7.4 GSK
  7.4.1 GSK Corporate Summary
  7.4.2 GSK Business Overview
  7.4.3 GSK Anti-Smoking Products Major Product Offerings
  7.4.4 GSK Anti-Smoking Products Revenue in Global Market (2017-2022)
  7.4.5 GSK Key News
7.5 Takeda pharmaceutical
  7.5.1 Takeda pharmaceutical Corporate Summary
  7.5.2 Takeda pharmaceutical Business Overview
  7.5.3 Takeda pharmaceutical Anti-Smoking Products Major Product Offerings
  7.5.4 Takeda pharmaceutical Anti-Smoking Products Revenue in Global Market (2017-2022)
  7.5.5 Takeda pharmaceutical Key News
7.6 McNeil AB
  7.6.1 McNeil AB Corporate Summary
  7.6.2 McNeil AB Business Overview
  7.6.3 McNeil AB Anti-Smoking Products Major Product Offerings
  7.6.4 McNeil AB Anti-Smoking Products Revenue in Global Market (2017-2022)
  7.6.5 McNeil AB Key News
7.7 Revolymer plc
  7.7.1 Revolymer plc Corporate Summary
  7.7.2 Revolymer plc Business Overview
  7.7.3 Revolymer plc Anti-Smoking Products Major Product Offerings
  7.7.4 Revolymer plc Anti-Smoking Products Revenue in Global Market (2017-2022)
  7.7.5 Revolymer plc Key News
7.8 Imperial Tobacco
  7.8.1 Imperial Tobacco Corporate Summary
  7.8.2 Imperial Tobacco Business Overview
  7.8.3 Imperial Tobacco Anti-Smoking Products Major Product Offerings
  7.8.4 Imperial Tobacco Anti-Smoking Products Revenue in Global Market (2017-2022)
  7.8.5 Imperial Tobacco Key News
7.9 Elder Pharma
  7.9.1 Elder Pharma Corporate Summary
  7.9.2 Elder Pharma Business Overview
  7.9.3 Elder Pharma Anti-Smoking Products Major Product Offerings
  7.9.4 Elder Pharma Anti-Smoking Products Revenue in Global Market (2017-2022)
  7.9.5 Elder Pharma Key News
7.10 NJOY
  7.10.1 NJOY Corporate Summary
  7.10.2 NJOY Business Overview
  7.10.3 NJOY Anti-Smoking Products Major Product Offerings
  7.10.4 NJOY Anti-Smoking Products Revenue in Global Market (2017-2022)
  7.10.5 NJOY Key News
7.11 VMR products
  7.11.1 VMR products Corporate Summary
  7.11.2 VMR products Business Overview
  7.11.3 VMR products Anti-Smoking Products Major Product Offerings
  7.11.4 VMR products Anti-Smoking Products Revenue in Global Market (2017-2022)
  7.11.5 VMR products Key News
7.12 Lorillard
  7.12.1 Lorillard Corporate Summary
  7.12.2 Lorillard Business Overview
  7.12.3 Lorillard Anti-Smoking Products Major Product Offerings
  7.12.4 Lorillard Anti-Smoking Products Revenue in Global Market (2017-2022)
  7.12.5 Lorillard Key News
7.13 VaporCorp
  7.13.1 VaporCorp Corporate Summary
  7.13.2 VaporCorp Business Overview
  7.13.3 VaporCorp Anti-Smoking Products Major Product Offerings
  7.13.4 VaporCorp Anti-Smoking Products Revenue in Global Market (2017-2022)
  7.13.5 VaporCorp Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Anti-Smoking Products Market Opportunities & Trends in Global Market
Table 2. Anti-Smoking Products Market Drivers in Global Market
Table 3. Anti-Smoking Products Market Restraints in Global Market
Table 4. Key Players of Anti-Smoking Products in Global Market
Table 5. Top Anti-Smoking Products Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Anti-Smoking Products Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Anti-Smoking Products Revenue Share by Companies, 2017-2022
Table 8. Global Companies Anti-Smoking Products Product Type
Table 9. List of Global Tier 1 Anti-Smoking Products Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Smoking Products Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Anti-Smoking Products Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Anti-Smoking Products Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Anti-Smoking Products Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Anti-Smoking Products Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Anti-Smoking Products Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Anti-Smoking Products Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Anti-Smoking Products Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Anti-Smoking Products Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Anti-Smoking Products Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Anti-Smoking Products Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Anti-Smoking Products Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Anti-Smoking Products Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Anti-Smoking Products Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Anti-Smoking Products Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Anti-Smoking Products Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Anti-Smoking Products Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Anti-Smoking Products Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Anti-Smoking Products Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Anti-Smoking Products Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Anti-Smoking Products Product Offerings
Table 32. Pfizer Anti-Smoking Products Revenue (US$, Mn), (2017-2022)
Table 33. Cipla Corporate Summary
Table 34. Cipla Anti-Smoking Products Product Offerings
Table 35. Cipla Anti-Smoking Products Revenue (US$, Mn), (2017-2022)
Table 36. Novartis International Corporate Summary
Table 37. Novartis International Anti-Smoking Products Product Offerings
Table 38. Novartis International Anti-Smoking Products Revenue (US$, Mn), (2017-2022)
Table 39. GSK Corporate Summary
Table 40. GSK Anti-Smoking Products Product Offerings
Table 41. GSK Anti-Smoking Products Revenue (US$, Mn), (2017-2022)
Table 42. Takeda pharmaceutical Corporate Summary
Table 43. Takeda pharmaceutical Anti-Smoking Products Product Offerings
Table 44. Takeda pharmaceutical Anti-Smoking Products Revenue (US$, Mn), (2017-2022)
Table 45. McNeil AB Corporate Summary
Table 46. McNeil AB Anti-Smoking Products Product Offerings
Table 47. McNeil AB Anti-Smoking Products Revenue (US$, Mn), (2017-2022)
Table 48. Revolymer plc Corporate Summary
Table 49. Revolymer plc Anti-Smoking Products Product Offerings
Table 50. Revolymer plc Anti-Smoking Products Revenue (US$, Mn), (2017-2022)
Table 51. Imperial Tobacco Corporate Summary
Table 52. Imperial Tobacco Anti-Smoking Products Product Offerings
Table 53. Imperial Tobacco Anti-Smoking Products Revenue (US$, Mn), (2017-2022)
Table 54. Elder Pharma Corporate Summary
Table 55. Elder Pharma Anti-Smoking Products Product Offerings
Table 56. Elder Pharma Anti-Smoking Products Revenue (US$, Mn), (2017-2022)
Table 57. NJOY Corporate Summary
Table 58. NJOY Anti-Smoking Products Product Offerings
Table 59. NJOY Anti-Smoking Products Revenue (US$, Mn), (2017-2022)
Table 60. VMR products Corporate Summary
Table 61. VMR products Anti-Smoking Products Product Offerings
Table 62. VMR products Anti-Smoking Products Revenue (US$, Mn), (2017-2022)
Table 63. Lorillard Corporate Summary
Table 64. Lorillard Anti-Smoking Products Product Offerings
Table 65. Lorillard Anti-Smoking Products Revenue (US$, Mn), (2017-2022)
Table 66. VaporCorp Corporate Summary
Table 67. VaporCorp Anti-Smoking Products Product Offerings
Table 68. VaporCorp Anti-Smoking Products Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Anti-Smoking Products Segment by Type in 2021
Figure 2. Anti-Smoking Products Segment by Application in 2021
Figure 3. Global Anti-Smoking Products Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Anti-Smoking Products Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anti-Smoking Products Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-Smoking Products Revenue in 2021
Figure 8. By Type - Global Anti-Smoking Products Revenue Market Share, 2017-2028
Figure 9. By Application - Global Anti-Smoking Products Revenue Market Share, 2017-2028
Figure 10. By Region - Global Anti-Smoking Products Revenue Market Share, 2017-2028
Figure 11. By Country - North America Anti-Smoking Products Revenue Market Share, 2017-2028
Figure 12. US Anti-Smoking Products Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Anti-Smoking Products Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Anti-Smoking Products Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Anti-Smoking Products Revenue Market Share, 2017-2028
Figure 16. Germany Anti-Smoking Products Revenue, (US$, Mn), 2017-2028
Figure 17. France Anti-Smoking Products Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Anti-Smoking Products Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Anti-Smoking Products Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Anti-Smoking Products Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Anti-Smoking Products Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Anti-Smoking Products Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Anti-Smoking Products Revenue Market Share, 2017-2028
Figure 24. China Anti-Smoking Products Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Anti-Smoking Products Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Anti-Smoking Products Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Anti-Smoking Products Revenue, (US$, Mn), 2017-2028
Figure 28. India Anti-Smoking Products Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Anti-Smoking Products Revenue Market Share, 2017-2028
Figure 30. Brazil Anti-Smoking Products Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Anti-Smoking Products Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Anti-Smoking Products Revenue Market Share, 2017-2028
Figure 33. Turkey Anti-Smoking Products Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Anti-Smoking Products Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Anti-Smoking Products Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Anti-Smoking Products Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Anti-Smoking Products Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Cipla Anti-Smoking Products Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis International Anti-Smoking Products Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. GSK Anti-Smoking Products Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Takeda pharmaceutical Anti-Smoking Products Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. McNeil AB Anti-Smoking Products Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Revolymer plc Anti-Smoking Products Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Imperial Tobacco Anti-Smoking Products Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Elder Pharma Anti-Smoking Products Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. NJOY Anti-Smoking Products Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. VMR products Anti-Smoking Products Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Lorillard Anti-Smoking Products Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. VaporCorp Anti-Smoking Products Revenue Year Over Year Growth (US$, Mn) & (2017-2022)